Home

PM ytterligare Avvika teva new ms drug transient Rynka pannan Åsna

Better Late Than Never: Novartis, Momenta Win FDA Approval for Delayed MS Drug | BioSpace
Better Late Than Never: Novartis, Momenta Win FDA Approval for Delayed MS Drug | BioSpace

Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times

Teva | Partnership | Direct Relief
Teva | Partnership | Direct Relief

Novartis' Gilenya tops Teva giant Copaxone in head-to-head MS study | Fierce Pharma
Novartis' Gilenya tops Teva giant Copaxone in head-to-head MS study | Fierce Pharma

Teva names new CFO and bulks up its opioid liability fund - PMLiVE
Teva names new CFO and bulks up its opioid liability fund - PMLiVE

Teva loses key MS drug patent | Nature Reviews Drug Discovery
Teva loses key MS drug patent | Nature Reviews Drug Discovery

Teva steps up defence of key MS drug
Teva steps up defence of key MS drug

World MS Day, May 31, Marked by Teva's 'Life Moments with MS' Social Media Campaign
World MS Day, May 31, Marked by Teva's 'Life Moments with MS' Social Media Campaign

Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)
Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)

Teva knocked as competition fears grow for MS drug
Teva knocked as competition fears grow for MS drug

Teva and Active Biotech Expand Investigational MS Treatment Program
Teva and Active Biotech Expand Investigational MS Treatment Program

EU says Teva blocked generics to MS drug Copaxone | pharmaphorum
EU says Teva blocked generics to MS drug Copaxone | pharmaphorum

In blow to Teva, UK court rules in favor of Copaxone patent challenge | The Times of Israel
In blow to Teva, UK court rules in favor of Copaxone patent challenge | The Times of Israel

Feds accuse Teva of $300M in kickbacks for MS drug - Drug Discovery and Development
Feds accuse Teva of $300M in kickbacks for MS drug - Drug Discovery and Development

PTAB invalidates three patents covering Teva's Copaxone, opens door for Mylan's generic version - IPWatchdog.com | Patents & Intellectual Property Law
PTAB invalidates three patents covering Teva's Copaxone, opens door for Mylan's generic version - IPWatchdog.com | Patents & Intellectual Property Law

First generic version of Teva's Copaxone cleared by FDA - PMLiVE
First generic version of Teva's Copaxone cleared by FDA - PMLiVE

What are the implications of a generic Teva MS drug? Here's what the wags say - STAT
What are the implications of a generic Teva MS drug? Here's what the wags say - STAT

Swedish Biotech Faces Another Phase III Flop in Multiple Sclerosis
Swedish Biotech Faces Another Phase III Flop in Multiple Sclerosis

BCBS of Vermont sues Teva Pharmaceuticals over marketing for its MS drug Copaxone
BCBS of Vermont sues Teva Pharmaceuticals over marketing for its MS drug Copaxone

Teva launches Copaxone with the YpsoMate autoinjector from Ypsomed - Ypsomed - Canada
Teva launches Copaxone with the YpsoMate autoinjector from Ypsomed - Ypsomed - Canada

Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report
Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report

Teva and BioGen Locked in Dispute Over MS Drug Agreement | New Jersey Law Journal
Teva and BioGen Locked in Dispute Over MS Drug Agreement | New Jersey Law Journal

FDA Nod to New MS Drug Spells Trouble for Teva - Haaretz Com - Haaretz.com
FDA Nod to New MS Drug Spells Trouble for Teva - Haaretz Com - Haaretz.com

Teva Class Action Claims Company Suppressed Competition For Generic Version Of MS Drug Copaxone - Top Class Actions
Teva Class Action Claims Company Suppressed Competition For Generic Version Of MS Drug Copaxone - Top Class Actions

Federal Judge, Clarifying FCA Causation, Grants Feds Partial Summary Judgment | Law.com
Federal Judge, Clarifying FCA Causation, Grants Feds Partial Summary Judgment | Law.com